In the context of the current medical reform, high-quality and stable supply of APIs is a significant competing advantage. In order to consolidate the existing advantages of APIs and further guarantee the production and supply of high value-added APIs, YaoPharma’s international API industrial base in Changshou starts construction.　　

As one of the company’s important strategic layouts, the project will be built into an advanced production base for APIs in accordance with the design concept of environmental protection and advanced manufacturing to ensure stable supply of APIs and high value-added specialty APIs that used in production of anti-tumor drugs, anti-infection, anti-viral, and immunotherapy drugs.　　

On June 28, YaoPharma Co., Ltd and Chongqing Carelife Pharmaceutical Co., Ltd held a groundbreaking ceremony for “International API Industrial Base Project” in Changshou.　　

The project covers an area of about 400 acres and will build a modern API production base of about 200,000 m². The first phase project covers an area of 180 acres which can support the expansion of existing products and the conversion of part of products after completion. 　 　

The project is positioning to guarantee the supply of anti-tumor, anti-infection and other APIs. Relying on the advanced technology and product advantages of YaoPharma Co., Ltd and Chongqing Carelife Pharmaceutical Co., Ltd, it will be built into an environmental protection, advanced manufacturing and international standard API lighthouse factory in accordance with the design concept of advanced, green, and continuous production.

Project renderings 　 　

The project is another major API strategic investment of YaoPharma after the "International API Industrial Base" in Changde, Hunan. 　 　

It will consolidate the advantages of YaoPharma in anti-infection and anti-viral APIs, and further guarantee the supply of APIs for anti-tumor, immunotherapy and specialty drugs.